Psychedelics MAPS partners with diverse artist lineup for psychedelic music & education initiative The 'Music is the Bridge' campaign has created an assortment of playlists specifically made for psychedelic trips Rowan DunneDecember 9, 2024
Psychedelics Psycheceutical Bioscience develops non-psychoactive ketamine topical for PTSD and depression NeuroDirect Ketamine can also help alleviate headaches and migraines within minutes, with no trip involved Rowan DunneJune 14, 2023
Psychedelics Beckley Waves establishes ethics council for the psychedelics sector Beckley Waves was created by the Beckley Foundation's Founder Amanda Feilding Rowan DunneJune 1, 2023
News 67% of PTSD sufferers drop diagnosis in first MDMA Phase 3 trial Following the successful MAPS study, MDMA-assisted therapy moves closer to becoming approved by the US FDA Natalia Buendia CalvilloMay 4, 2021
Industry update Attend next week’s psychedelics legalization debate Thursday, April 27, four experts including MAPS founder Rick Doblin and former US drug policy advisor Kevin Sabet debate the merits of psychedelic reform Nick LabaApril 16, 2021
Industry update Low-THC weed led to poor results in major PTSD study US researchers seek DEA to permit potent pot production after long-awaited FDA-backed study shows weak weed ineffective at treating PTSD Jared GnamMarch 30, 2021